UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Wnt5A Activates the Calpain-Mediated Cleavage of Filamin A

Journal of investigative dermatology, 2009-07, Vol.129 (7), p.1782-1789

2009

Volltextzugriff (PDF)

Immuno-Expression of Human Melanoma Stem Cell Markers in Tissues at Different Stages of the Disease

The Journal of surgical research, 2010-09, Vol.163 (1), p.e11-e15

2010

Volltextzugriff (PDF)

The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy

Journal of the American College of Surgeons, 2003-09, Vol.197 (3), p.403-407

2003

Volltextzugriff (PDF)

New approach to adjuvant therapy in high-risk melanoma patients

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13129-e13129

Elias, E. George

2012

Volltextzugriff (PDF)

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma

Journal of Clinical Immunology, 2006-07, Vol.26 (4), p.331-338

2006

Volltextzugriff (PDF)

Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial

Cancer biotherapy & radiopharmaceuticals, 2008-06, Vol.23 (3), p.285-291

2008

Volltextzugriff (PDF)

Tumor response and patient survival after intralesional therapy with low-dose GM-CSF and IL-2 in metastatic and primary cutaneous melanoma: An exploratory study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20002-e20002

2014

Volltextzugriff (PDF)

Consequential administration of intralesional (intratumoral) GM-CSF and IL-2 in the management of metastatic and primary invasive cutaneous melanoma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20052-e20052

2013

Volltextzugriff (PDF)

GM-CSF and IL-2 combination as adjuvant therapy in cutaneous melanoma: early results of a phase II clinical trial

Oncology (Williston Park, N.Y.), 2005-04, Vol.19 (4 Suppl 2), p.15-18

2005

Volltextzugriff (PDF)

Head and Neck Sarcoma: Report of the Head and Neck Sarcoma Registry

Head & neck, 1992-01, Vol.14 (1), p.1-7

1992

Volltextzugriff (PDF)

Is there an established role for immunotherapy for any of our surgical cancers?

Journal of surgical oncology, 1991-11, Vol.48 (3), p.149-152

Elias, E. George

1991

Volltextzugriff (PDF)

Continuous abdominal fascial closure: a randomized controlled trial of poly( l-lactide/glycolide)

Gynecologic oncology, 2003-08, Vol.90 (2), p.342-347

2003

Volltextzugriff (PDF)

Experience with Methotrexate, 5-Fluorouracil, and Leucovorin (MFL): A First Line Effective, Minimally Toxic Regimen for Metastatic Breast Cancer

Cancer investigation, 2002, Vol.20 (1), p.24-28

2002

Volltextzugriff (PDF)

A Role for Intralesional (Intratumoral) Therapy with Two Cytokines in the Management of Some High Risk Patients with Cutaneous Melanoma

Surgery (Sunnyvale, Calif.), 2015, Vol.5 (2)

Bhuvnesh K Sharma, E George Elias

2015

Volltextzugriff (PDF)

Targeting Melanoma Sites in Vivo can Induce Complete Tumor Ablation and Prolong Patient Survival: An Exploratory Study

Journal of cancer science & therapy, 2013, Vol.5 (7)

Elias, E. George

2013

Volltextzugriff (PDF)

Adjuvant immunotherapy in melanoma: A new approach

Journal of surgical oncology, 1992-07, Vol.50 (3), p.144-148

1992

Volltextzugriff (PDF)

Adjuvant immunotherapy in melanoma with irradiated autologous tumor cells and low dose cyclophosphamide

Journal of surgical oncology, 1997-01, Vol.64 (1), p.17-22

1997

Volltextzugriff (PDF)

Treatment of primary breast cancer with chemotherapy and tamoxifen

The New England journal of medicine, 1981-07, Vol.305 (1), p.1-6

1981

Volltextzugriff (PDF)

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on depressed peripheral blood dendritic cell (DC) counts in patients with stage IIB–IV melanoma

Journal of the American College of Surgeons, 2004-09, Vol.199 (3), p.81-81

2004

Volltextzugriff (PDF)

An immunological aspect of melanoma and its potential application in adjuvant therapy

Journal of surgical oncology, 1991-12, Vol.48 (4), p.220-223

1991

Volltextzugriff (PDF)

The Effect of Sequential Administration of Human Granulocyte-Macrophage Colony Stimulation Factor (GM-CSF) and Interleukin-2 (IL-2): A New Postoperative Adjuvant Therapy in High-Risk Melanoma Patients

Southern medical journal (Birmingham, Ala.), 2003-11, Vol.96 (Supplement), p.S30-S31

2003

Volltextzugriff (PDF)

SURGICAL MANAGEMENT OF LIVER TUMORS

Southern medical journal (Birmingham, Ala.), 1995-10, Vol.88, p.S129

Elias, E. George

1995

Volltextzugriff (PDF)

Effects of different shortwave radiofrequencies on tumor growth

Cancer research (Chicago, Ill.), 1980-08, Vol.40 (8 Pt 1), p.2829-2834

1980

Volltextzugriff (PDF)

Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma

Diseases of the colon & rectum, 1974-01, Vol.17 (1), p.38-41

1974

Volltextzugriff (PDF)

Prognostic factors in squamous cell carcinoma of the larynx

The American journal of surgery, 1989-10, Vol.158 (4), p.314-317

1989

Volltextzugriff (PDF)

1 – 25 von 746

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(633)
Mit Volltextzugriff
(604)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Wnt5A Activates the Calpain-Mediated Cleavage of Filamin A

Immuno-Expression of Human Melanoma Stem Cell Markers in Tissues at Different Stages of the Disease

The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy

New approach to adjuvant therapy in high-risk melanoma patients

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma

Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial

Tumor response and patient survival after intralesional therapy with low-dose GM-CSF and IL-2 in metastatic and primary cutaneous melanoma: An exploratory study

Consequential administration of intralesional (intratumoral) GM-CSF and IL-2 in the management of metastatic and primary invasive cutaneous melanoma

GM-CSF and IL-2 combination as adjuvant therapy in cutaneous melanoma: early results of a phase II clinical trial

Head and Neck Sarcoma: Report of the Head and Neck Sarcoma Registry

Is there an established role for immunotherapy for any of our surgical cancers?

Continuous abdominal fascial closure: a randomized controlled trial of poly( l-lactide/glycolide)

Experience with Methotrexate, 5-Fluorouracil, and Leucovorin (MFL): A First Line Effective, Minimally Toxic Regimen for Metastatic Breast Cancer

A Role for Intralesional (Intratumoral) Therapy with Two Cytokines in the Management of Some High Risk Patients with Cutaneous Melanoma

Targeting Melanoma Sites in Vivo can Induce Complete Tumor Ablation and Prolong Patient Survival: An Exploratory Study

Adjuvant immunotherapy in melanoma: A new approach

Adjuvant immunotherapy in melanoma with irradiated autologous tumor cells and low dose cyclophosphamide

Treatment of primary breast cancer with chemotherapy and tamoxifen

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on depressed peripheral blood dendritic cell (DC) counts in patients with stage IIB–IV melanoma

An immunological aspect of melanoma and its potential application in adjuvant therapy

The Effect of Sequential Administration of Human Granulocyte-Macrophage Colony Stimulation Factor (GM-CSF) and Interleukin-2 (IL-2): A New Postoperative Adjuvant Therapy in High-Risk Melanoma Patients

SURGICAL MANAGEMENT OF LIVER TUMORS

Effects of different shortwave radiofrequencies on tumor growth

Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma

Prognostic factors in squamous cell carcinoma of the larynx

Aktive Filter

Suchergebnisse filtern